Melinta Raises $67M In Venture Capital For New Drug
Melinta Therapeutics, a privately held life sciences company developing new antibiotics to treat drug-resistant bacterial infections, said Wednesday it has raised $67 million in equity financing led by Irish biotech fund...To view the full article, register now.
Already a subscriber? Click here to view full article